Drug Trial Radar · NCT00634166
Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group
Last checked: Nov 19, 2026Latest source record: Sep 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
220
Actual
Start
Sep 2007
Primary completion
Dec 2013
Study completion Apr 2014
Sponsor
- Lead sponsor
- Mylan Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Mylan Bertek Pharmaceuticals
- First posted
- Mar 12, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 3 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective is to compare the effectiveness of treatment with Sulfamylon® solution as the initial topical moist dressing over meshed autografts following the initial graft procedure on preventing graft loss in a prospective cohort of subjects versus a historical control group in a non-inferiority trial.
Conditions
- Burns
Interventions
Sulfamylon® For 5 % Topical SolutionDrug
Sulfamylon® For 5% Topical Solution is indicated for use as an adjunctive topical antimicrobial agent to control bacterial infection when used under moist dressings over meshed autografts on excised burn wounds.
Topical Antimicrobial/Antifungal MedicationsDrug
'Topical Antimicrobial/Antifungal Medications' Various topical antimicrobials and antifungals include: Bacitracin; Amphotericin B; Silver Sulfadiazine; Cefazolin; Vancomycin; Nystatin; Fluconazole; Piperacillin Sodium with Tazobactam.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Graft Loss After Initial Meshed Autograft Procedure on Days 5-7.Time frame: The primary analysis will compare the percent of subjects with All Cause Graft Loss of the initial meshed autograft procedure at Days 5-7.
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
University of South Alabama Medical Center
Mobile, Alabama
Arrowhead Regional Medical Center
Redlands, California
Shands Burn Center - Univ. of Florida
Gainesville, Florida
Loyola University Medical Center
Maywood, Illinois
The Plastic Surgery Institute - Southern Illinois Univ. School of Medicine
Springfield, Illinois
University of Kansas Medical Center
Kansas City, Kansas
John's Hopkins Burn Center
Baltimore, Maryland
University of Missouri Healthcare - Dept. of Surgery
Columbia, Missouri
Wake Forest University - Department of General Surgery
Winston-Salem, North Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.